Re-entry ventricular arrhythmia
Re-entry ventricular arrhythmia | |
---|---|
Synonyms | Reentrant ventricular arrhythmia |
Pronounce | N/A |
Specialty | N/A |
Symptoms | Palpitations, dizziness, syncope, chest pain, shortness of breath |
Complications | Sudden cardiac death, heart failure |
Onset | Sudden |
Duration | Variable |
Types | N/A |
Causes | Re-entry circuit in the ventricles |
Risks | Coronary artery disease, cardiomyopathy, myocardial infarction, heart surgery |
Diagnosis | Electrocardiogram (ECG), Holter monitor, electrophysiological study |
Differential diagnosis | Atrial fibrillation, ventricular tachycardia, ventricular fibrillation |
Prevention | Beta blockers, antiarrhythmic drugs, catheter ablation |
Treatment | Medications, implantable cardioverter-defibrillator (ICD), radiofrequency ablation |
Medication | N/A |
Prognosis | Variable, depends on underlying condition and treatment |
Frequency | Common in patients with structural heart disease |
Deaths | N/A |
Re-entry Ventricular Arrhythmia is a type of cardiac arrhythmia that occurs when a disturbance in the heart's electrical conduction system leads to rapid, uncoordinated heartbeats originating in the ventricles, the lower chambers of the heart. This condition is a significant concern because it can compromise cardiac output and lead to serious complications, including sudden cardiac death.
Causes
Re-entry ventricular arrhythmia is primarily caused by the presence of a "re-entry circuit" within the heart's ventricular tissue. This situation can arise due to various factors, including:
- Myocardial infarction (heart attack), which can create scar tissue that disrupts the normal flow of electrical impulses.
- Cardiomyopathy, a disease of the heart muscle that affects its size, shape, and structure.
- Electrolyte imbalances, particularly involving potassium and magnesium, which are critical for the proper electrical functioning of the heart.
- Genetic conditions, such as Long QT Syndrome and Brugada Syndrome, which affect the heart's electrical properties.
Symptoms
Symptoms of re-entry ventricular arrhythmia can vary widely among individuals, ranging from no symptoms at all to severe manifestations, including:
- Palpitations, a sensation of the heart racing or pounding
- Dizziness or lightheadedness
- Syncope (fainting)
- Chest pain
- In severe cases, cardiac arrest
Diagnosis
Diagnosis of re-entry ventricular arrhythmia involves a combination of clinical evaluation and diagnostic tests, including:
- Electrocardiogram (ECG or EKG), which records the electrical activity of the heart and can identify abnormal rhythms.
- Holter monitor, a portable ECG device worn for 24 hours or longer to record the heart's activity over time.
- Electrophysiological study (EPS), an invasive test where catheters are inserted into the heart to study its electrical system and identify re-entry circuits.
Treatment
Treatment for re-entry ventricular arrhythmia aims to prevent future episodes and reduce the risk of complications. Options include:
- Antiarrhythmic drugs, which help regulate the heart's rhythm.
- Catheter ablation, a procedure that destroys the tissue forming the re-entry circuit, thereby interrupting the abnormal electrical pathway.
- Implantable cardioverter-defibrillator (ICD), a device implanted in the chest to monitor the heart's rhythm and deliver electrical shocks when a dangerous arrhythmia is detected.
- Lifestyle modifications, including dietary changes, exercise, and avoiding triggers like alcohol and caffeine, may also be recommended.
Prognosis
The prognosis for individuals with re-entry ventricular arrhythmia varies depending on the underlying cause, the presence of heart disease, and the effectiveness of treatment. With appropriate management, many patients can lead normal, active lives.
See Also
This article is a cardiovascular system stub. You can help WikiMD by expanding it!
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD